Skip to content

13F-HR filed by Artal Group S.A.

Artal Group S.A. filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-11, with 130 holding rows worth $4,658,177,000.

Accession
0001053906-21-000002
Filed
2021-02-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2020

A holdings report, 132 entries on the cover page, a total value of $4,658,177,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,658,177,000 with VALUE read as thousands by filing date, 13F file number 028-15027. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
WW INTL INC98262P101COM14,818,300$361,566,000thousands by filing date
SEER INC81578P106COM CL A5,840,911$327,909,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR1,000,000$258,390,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK71,178,364$243,430,000thousands by filing date
ACCELERON PHARMA INC00434H108COM1,400,000$179,116,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM1,400,000$127,302,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM500,000$109,820,000thousands by filing date
IGM BIOSCIENCES INC449585108COM1,200,000$105,948,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock800,000$103,976,000thousands by filing date
SCHOLAR ROCK HLDG CORP80706P103COM2,100,000$101,913,000thousands by filing date
GDS HLDGS LTD SPONSORED ADS36165L108ADR1,000,000$93,640,000thousands by filing date
ALLOVIR INC019818103COM2,323,371$89,310,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR300,000$88,227,000thousands by filing date
AbbVie,Inc.00287Y109COM800,000$85,720,000thousands by filing datecall
BIONTECH SE SPONSORED ADS09075V102ADR1,000,000$81,520,000thousands by filing date
GENERATION BIO CO37148K100COM2,814,191$79,782,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock1,500,000$78,030,000thousands by filing date
ZILLOW GROUP INC CL C CAP STK98954M200Stock550,000$71,390,000thousands by filing date
SCHRODINGER INC COM80810D103Stock797,445$63,142,000thousands by filing date
Bristol-Myers Squibb Company110122108COM1,000,000$62,030,000thousands by filing datecall
KE HLDGS INC SPONSORED ADS482497104ADR1,000,000$61,540,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM2,500,000$57,725,000thousands by filing date
MORPHIC HLDG INC61775R105COM1,651,686$55,414,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock2,800,000$54,964,000thousands by filing date
BLACK DIAMOND THERAPEUTICS I09203E105COM1,646,517$52,771,000thousands by filing date
SQZ BIOTECHNOLOGIES CO78472W104COM1,606,308$46,551,000thousands by filing date
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS200,000$46,546,000thousands by filing date
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS200,000$46,546,000thousands by filing datecall
TURNING PT THERAPEUTICS90041T108COM350,000$42,648,000thousands by filing date
PRAXIS PRECISION MEDICINES I74006W108COM750,000$41,265,000thousands by filing date
CHEMOCENTRYX INC16383L106COM650,000$40,248,000thousands by filing date
KRONOS BIO INC50107A104COM1,317,954$39,367,000thousands by filing date
CEREVEL THERAPEUTICS HLDNG I15678U128COM2,282,100$37,837,000thousands by filing date
ITEOS THERAPEUTICS INC46565G104COM1,094,047$37,001,000thousands by filing date
FOGHORN THERAPEUTICS INC344174107COMMON STOCK1,720,720$34,879,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM400,000$34,604,000thousands by filing date
NOVABRIDGE BIOSCIENCES44975P103CMN725,000$34,184,000thousands by filing date
DENALI THERAPEUTICS INC COM24823R105Stock400,000$33,504,000thousands by filing date
SPRINGWORKS THERAPEUTICS INC85205L107COM450,000$32,634,000thousands by filing date
Mersana Therapeutics Inc59045L106Common Stock1,200,000$31,932,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock2,100,000$30,891,000thousands by filing date
RUBIUS THERAPEUTICS INC78116T103COM3,778,913$28,682,000thousands by filing date
DECIPHERA PHARMACEUTICALS IN24344T101COM500,000$28,535,000thousands by filing date
TAYSHA GENE THERAPIES INC877619106COMMON STOCK1,040,882$27,625,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock2,500,000$27,100,000thousands by filing date
REPLIMUNE GROUP INC76029N106COMMON STOCK700,000$26,705,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK700,000$26,257,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock200,000$25,994,000thousands by filing datecall
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK300,000$25,860,000thousands by filing date
UNIQURE NVN90064101SHS700,000$25,291,000thousands by filing date
NOVAGOLD RESOURCES INC66987E206COM NEW2,600,000$25,142,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM1,000,000$23,090,000thousands by filing datecall
GOSSAMER BIO INC COM38341P102Stock2,358,968$22,811,000thousands by filing date
TRANSLATE BIO INC.89374L104Common Stock1,200,000$22,116,000thousands by filing date
AGENUS INC00847G705COM NEW6,900,000$21,942,000thousands by filing date
Schlumberger Limited806857108COM1,000,000$21,830,000thousands by filing datecall
BRIDGEBIO PHARMA INC10806X102COM300,000$21,333,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock600,000$19,596,000thousands by filing date
REPARE THERAPEUTICS INC760273102COM570,000$19,551,000thousands by filing date
BIO-TECHNE CORP09073M104COM60,000$19,053,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM400,000$18,560,000thousands by filing date
FORMA THERAPEUTICS HLDGS INC34633R104SHS500,000$17,450,000thousands by filing date
TRIP COM GROUP LTD ADS89677Q107ADR500,000$16,865,000thousands by filing date
RELAY THERAPEUTICS INC COM75943R102Stock400,000$16,624,000thousands by filing date
ZYMEWORKS INC98985W102COM350,000$16,541,000thousands by filing date
NANOBIOTIX63009J107SPONSORED ADS1,000,000$16,500,000thousands by filing date
CARDIFF ONCOLOGY INC14147L108COM900,000$16,191,000thousands by filing date
KYMERA THERAPEUTICS INC501575104COM250,000$15,500,000thousands by filing date
STOKE THERAPEUTICS INC86150R107COM250,000$15,483,000thousands by filing date
TCR2 THERAPEUTICS INC87808K106COM500,000$15,465,000thousands by filing date
IQIYI INC SPONSORED ADS46267X108ADR850,000$14,858,000thousands by filing date
FIBROGEN INC31572Q808COM400,000$14,836,000thousands by filing date
CURIS INC231269200COM1,804,729$14,781,000thousands by filing date
BELLUS HEALTH INC NEW07987C204COM4,750,000$14,535,000thousands by filing date
KRYSTAL BIOTECH INC COM501147102Stock237,500$14,250,000thousands by filing date
Y-mAbs Therapeutics Inc984241109Common Stock285,028$14,112,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock1,000,000$13,830,000thousands by filing date
SELECTA BIOSCIENCES INC816212104COM4,500,000$13,635,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM250,000$13,600,000thousands by filing date
HARPOON THERAPEUTICS INC41358P106COM800,000$13,288,000thousands by filing date
SIGILON THERAPEUTICS INC82657L107COM276,000$13,256,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM150,000$13,154,000thousands by filing datecall
OLEMA PHARMACEUTICALS INC68062P106COM260,500$12,525,000thousands by filing date
Danaher Corporation235851102COM50,000$11,107,000thousands by filing date
IMMUNIC INC4525EP101COM700,000$10,703,000thousands by filing date
HOOKIPA PHARMA INC43906K100COM949,616$10,531,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW500,000$10,390,000thousands by filing date
SPERO THERAPEUTICS INC84833T103COM500,000$9,695,000thousands by filing date
BRUKER CORP116794108COM175,275$9,488,000thousands by filing date
APTINYX INC03836N103COM2,502,035$8,657,000thousands by filing date
EVELO BIOSCIENCES INC299734103COM700,000$8,463,000thousands by filing date
Applied Therapeutics Inc03828A101Common Stock380,000$8,364,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM1,045,000$8,224,000thousands by filing date
SYROS PHARMACEUTICALS INC87184Q107COM750,000$8,138,000thousands by filing date
AMERICAN AIRLINES GROUP INC COM02376R102Stock500,000$7,885,000thousands by filing datecall
ALPINE IMMUNE SCIENCES INC02083G100COM593,030$7,472,000thousands by filing date
Aravive Inc03890D108Common / Ordinary Stock1,311,291$7,396,000thousands by filing date
METACRINE INC59101E103COM924,898$7,270,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW400,000$7,008,000thousands by filing date
111 INC68247Q102ADR1,000,000$6,950,000thousands by filing date
LEAP THERAPEUTICS INC52187K101COM3,000,000$6,750,000thousands by filing date
DYNE THERAPEUTICS INC COM26818M108Stock300,000$6,300,000thousands by filing date
OVID THERAPEUTICS INC690469101COMMON STOCK2,500,000$5,775,000thousands by filing date
CYCLERION THERAPEUTICS INC23255M105COM1,817,584$5,561,000thousands by filing date
MODERNA INC60770K107COM50,000$5,224,000thousands by filing date
AC IMMUNE SAH00263105SHS1,000,000$5,170,000thousands by filing date
CONTRAFECT CORP212326300COM1,000,000$5,050,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO1,196,218$5,024,000thousands by filing date
KINNATE BIOPHARMA INC49705R105COM125,000$4,973,000thousands by filing date
SERES THERAPEUTICS INC81750R102COM200,000$4,900,000thousands by filing date
KALEIDO BIOSCIENCES INC483347100COM500,500$4,555,000thousands by filing date
AXCELLA HEALTH INC05454B105COM712,500$3,698,000thousands by filing date
YUMANITY THERAPEUTICS INC98872L102COM217,391$3,696,000thousands by filing date
MARINUS PHARMACEUTICALS INC56854Q200COM NEW300,000$3,660,000thousands by filing date
AVIDITY BIOSCIENCES INC COM05370A108Stock142,500$3,637,000thousands by filing date
ORIC PHARMACEUTICALS INC68622P109COM100,000$3,385,000thousands by filing date
ADC THERAPEUTICS SAH0036K147COMMON STOCK95,000$3,041,000thousands by filing date
CHINOOK THERAPEUTICS INC16961L106COM180,500$2,863,000thousands by filing date
PROTAGONIST THERAPEUTICS74366E102COM133,000$2,681,000thousands by filing date
MEI PHARMA INC55279B202COM NEW760,000$2,006,000thousands by filing date
Energy Select Sector SPDR Fund81369Y506SHS50,000$1,895,000thousands by filing datecall
IDERA PHARMACEUTICALS INC45168K405COM PAR500,000$1,835,000thousands by filing date
ADICET BIO INC007002108COM129,335$1,817,000thousands by filing date
CHIASMA INC16706W102COM380,000$1,653,000thousands by filing date
ORCHARD THERAPEUTICS PLC68570P101ADR351,500$1,518,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK110,532$1,258,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK321,100$1,124,000thousands by filing date
SURFACE ONCOLOGY INC86877M209COM100,000$924,000thousands by filing date
CEREVEL THERAPEUTICS HLDNG I15678U102*W EXP 06/09/20279,600$450,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock224,675$449,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001053906-21-000002this filing2021-02-11acceptance time not in the bulk data set